MNIVF (Monash IVF Group) Research & Development: $0.0 Mil (TTM As of Dec. 2025)


MNIVF Monash IVF Group Ltd MNIVF
76 GF Score
Price $0.40
GF Value $0.78
! 8 Warning Signs
View Full Analysis

What is Monash IVF Group Research & Development?

Monash IVF Group MNIVF 76 Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus rates MNIVF with a GF Score™ of 76/100 and a GF Value™ of $0.78. The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Monash IVF Group's Research & Development for the six months ended in Dec. 2025 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.0 Mil.

Monash IVF Group  (OTCPK:MNIVF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Monash IVF Group Research & Development Related Terms

Monash IVF Group Research & Development Historical Data

* Premium members only.

The historical data trend for Monash IVF Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Monash IVF Group Research & Development Chart

Monash IVF Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Monash IVF Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MNIVF
76GF Score
Monash IVF Group Ltd MNIVF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Monash IVF Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
Monash IVF Group (MNIVF) has a Research & Development of $0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Monash IVF Group and its competitors.
Is Monash IVF Group's Research & Development too high?
Monash IVF Group's current Research & Development is $0.0 Mil. Overall, Monash IVF Group has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Monash IVF Group's Research & Development compare to TMO and DHR?
Monash IVF Group's Research & Development of $0.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Diagnostics & Research company?
A good Research & Development depends on the Medical Diagnostics & Research industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Monash IVF Group and its competitors. Monash IVF Group's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monash IVF Group stock overvalued right now?
Monash IVF Group (MNIVF) has a current Research & Development of $0.0 Mil. The stock's GF Value™ is $0.78, compared to a current price of $0.40 — trading 48.7% below its estimated fair value. The current Research & Development is $0.0 Mil. Monash IVF Group's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Monash IVF Group (MNIVF), the current Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Monash IVF Group (MNIVF) Overvalued in 2026?

Based on GuruFocus' analysis, Monash IVF Group stock appears to be undervalued. The current stock price of $0.40 is trading 48.7% below its estimated GF Value™ of $0.78.

Key valuation signals for MNIVF:

  • Research & Development: $0.0 Mil
  • GF Value™: $0.78 vs. price of $0.40 (48.7% below fair value)
  • GF Score™: 76/100 with 8 warning signs

No single metric tells the full story. See the MNIVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Monash IVF Group Business Description

Other Exchanges MVF:Australia
Address 510 Church Street, Level 1, Cremorne, VIC, AUS, 3121
Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women's health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.
76GF Score

Get the complete analysis for MNIVF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40
Price
$0.78
GF Value